CoChat
Sign Up
Cited by 89

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases

Alberini, Cristina M.·2023·Trends in Neurosciences
DOI 10.1016/j.tins.2023.03.007PMC PMC10192130
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tins.2023.03.007

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 103

  1. Rinderknecht, 1978, Primary structure of human insulin-like growth factor II, FEBS Lett., 89, 283, 10.1016/0014-5793(78)80237-3 · DOI
  2. LeRoith, 2021, Insulin-like growth factors: ligands, binding proteins, and receptors, Mol. Metab., 52, 10.1016/j.molmet.2021.101245 · DOI
  3. Lewitt, 2019, The role of insulin-like growth factors and insulin-like growth factor-binding proteins in the nervous system, Biochem. Insights, 12, 10.1177/1178626419842176 · DOI
  4. Chao, 2008, IGF2: epigenetic regulation and role in development and disease, Cytokine Growth Factor Rev., 19, 111, 10.1016/j.cytogfr.2008.01.005 · DOI
  5. Pardo, 2019, Insulin growth factor 2 (IGF2) as an emergent target in psychiatric and neurological disorders. Review, Neurosci. Res., 149, 1, 10.1016/j.neures.2018.10.012 · DOI
  6. Livingstone, 2014, Insulin-like growth factor-II: its role in metabolic and endocrine disease, Clin. Endocrinol., 80, 773, 10.1111/cen.12446 · DOI
  7. El-Shewy, 2009, Insulin-like growth factor-2/mannose-6 phosphate receptors, Vitam. Horm., 80, 667, 10.1016/S0083-6729(08)00624-9 · DOI
  8. Wang, 2017, Insulin-like growth factor-II/cation-independent mannose 6-phosphate receptor in neurodegenerative diseases, Mol. Neurobiol., 54, 2636, 10.1007/s12035-016-9849-7 · DOI
  9. Nadimpalli, 2010, Evolution of mannose 6-phosphate receptors (MPR300 and 46): lysosomal enzyme sorting proteins, Curr. Protein Pept. Sci., 1, 68, 10.2174/138920310790274644 · DOI
  10. Ghosh, 2003, Mannose 6-phosphate receptors: new twists in the tale, Nat. Rev. Mol. Cell Biol., 4, 202, 10.1038/nrm1050 · DOI
  11. DeChiara, 1990, A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting, Nature, 345, 78, 10.1038/345078a0 · DOI
  12. Louvi, 1997, Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development, Dev. Biol., 189, 33, 10.1006/dbio.1997.8666 · DOI
  13. Beletskiy, 2021, Insulin-like growth factor 2 as a possible neuroprotective agent and memory enhancer-its comparative expression, processing and signaling in mammalian CNS, Int. J. Mol. Sci., 22, 1849, 10.3390/ijms22041849 · DOI
  14. Lui, 2013, Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3, Proc. Natl. Acad. Sci. U. S. A., 110, 6181, 10.1073/pnas.1219079110 · DOI
  15. Lee, 1990, Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis, Development, 110, 151, 10.1242/dev.110.1.151 · DOI
  16. Sussenbach, 1993, Transcriptional and post-transcriptional regulation of the human IGF-II gene expression, Adv. Exp. Med. Biol., 343, 63, 10.1007/978-1-4615-2988-0_7 · DOI
  17. Daughaday, 1989, Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations, Endocr. Rev., 10, 68, 10.1210/edrv-10-1-68 · DOI
  18. DeChiara, 1991, Parental imprinting of the mouse insulin-like growth factor II gene, Cell, 64, 849, 10.1016/0092-8674(91)90513-X · DOI
  19. Giannoukakis, 1993, Parental genomic imprinting of the human IGF2 gene, Nat. Genet., 4, 98, 10.1038/ng0593-98 · DOI
  20. Begemann, 2012, Clinical significance of copy number variations in the 11p15.5 imprinting control regions: new cases and review of the literature, J. Med. Genet., 49, 547, 10.1136/jmedgenet-2012-100967 · DOI
  21. Alfares, 2018, Insulin-like growth factor-II in adipocyte regulation: depot-specific actions suggest a potential role limiting excess visceral adiposity, Am. J. Physiol. Endocrinol. Metab., 315, E1098, 10.1152/ajpendo.00409.2017 · DOI
  22. Sandovici, 2021, Autocrine IGF2 programmes β-cell plasticity under conditions of increased metabolic demand, Sci. Rep., 11, 7717, 10.1038/s41598-021-87292-x · DOI
  23. Zierath, 1992, Insulin-like growth factor II stimulates glucose transport in human skeletal muscle, FEBS Lett., 307, 379, 10.1016/0014-5793(92)80717-U · DOI
  24. Sandovici, 2022, The imprinted Igf2-Igf2r axis is critical for matching placental microvasculature expansion to fetal growth, Dev. Cell, 57, 63, 10.1016/j.devcel.2021.12.005 · DOI
  25. Scalia, 2020, The IGF-II-insulin receptor isoform-A autocrine signal in cancer: actionable perspectives, Cancers (Basel), 12, 366, 10.3390/cancers12020366 · DOI
  26. Faienza, 2010, IGF2 gene variants and risk of hypertension in obese children and adolescents, Pediatr. Res., 67, 340, 10.1203/PDR.0b013e3181d22757 · DOI
  27. Chen, 2011, A critical role for IGF-II in memory consolidation and enhancement, Nature, 469, 491, 10.1038/nature09667 · DOI
  28. Agis-Balboa, 2011, A hippocampal insulin-growth factor 2 pathway regulates the extinction of fear memories, EMBO J., 30, 4071, 10.1038/emboj.2011.293 · DOI
  29. Sélénou, 2022, IGF2: development, genetic and epigenetic abnormalities, Cells, 11, 1886, 10.3390/cells11121886 · DOI
  30. Ye, 2015, Insulin like growth factor 2 expression in the rat brain both in basal condition and following learning predominantly derives from the maternal allele, PLoS One, 10, 10.1371/journal.pone.0141078 · DOI
  31. Lau, 1994, Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality, Genes Dev., 8, 2953, 10.1101/gad.8.24.2953 · DOI
  32. Yu, 2020, A role for CIM6P/IGF2 receptor in memory consolidation and enhancement, eLife, 9, 10.7554/eLife.54781 · DOI · Paper page
  33. Schmeisser, 2012, IκB kinase/nuclear factor κB-dependent insulin-like growth factor 2 (Igf2) expression regulates synapse formation and spine maturation via Igf2 receptor signaling, J. Neurosci., 32, 5688, 10.1523/JNEUROSCI.0111-12.2012 · DOI
  34. Concina, 2021, Expression of IGF-2 receptor in the auditory cortex improves the precision of recent fear memories and maintains detailed remote fear memories over time, Cereb. Cortex, 31, 5381, 10.1093/cercor/bhab165 · DOI
  35. Stern, 2014, Enhancement of memories by systemic administration of insulin-like growth factor II, Neuropsychopharmacology, 39, 2179, 10.1038/npp.2014.69 · DOI
  36. Stern, 2014, The effect of insulin and insulin-like growth factors on hippocampus- and amygdala-dependent long-term memory formation, Learn. Mem., 21, 556, 10.1101/lm.029348.112 · DOI · Paper page
  37. Duan, 2020, BET proteins inhibitor JQ-1 impaired the extinction of remote auditory fear memory: an effect mediated by insulin like growth factor 2, Neuropharmacology, 177, 10.1016/j.neuropharm.2020.108255 · DOI
  38. Luo, 2020, The developmental and experience-dependent expression of IGF-2 in mice visual cortex, Neurosci. Lett., 721, 10.1016/j.neulet.2020.134828 · DOI
  39. Steinmetz, 2016, Insulin-like growth factor 2 rescues aging-related memory loss in rats, Neurobiol. Aging, 44, 9, 10.1016/j.neurobiolaging.2016.04.006 · DOI
  40. Steinmetz, 2018, Insulin-like growth factor II targets the mTOR pathway to reverse autism-like phenotypes in mice, J. Neurosci., 38, 1015, 10.1523/JNEUROSCI.2010-17.2017 · DOI
  41. Cruz, 2021, CIM6P/IGF-2 receptor ligands reverse deficits in Angelman syndrome model mice, Autism Res., 14, 29, 10.1002/aur.2418 · DOI
  42. Alberini, 2014, The regulation of transcription in memory consolidation, Cold Spring Harb. Perspect. Biol., 7
  43. Kukushkin, 2019, Neurotropic and modulatory effects of insulin-like growth factor II in Aplysia, Sci. Rep., 9, 14379, 10.1038/s41598-019-50923-5 · DOI
  44. Suh, 2010, Insulin-like growth factor 2 receptor is an IFNγ-inducible microglial protein that facilitates intracellular HIV replication: implications for HIV-induced neurocognitive disorders, Am. J. Pathol., 177, 2446, 10.2353/ajpath.2010.100399 · DOI
  45. Kar, 2006, Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer’s disease pathology, Neurobiol. Aging, 27, 199, 10.1016/j.neurobiolaging.2005.03.005 · DOI
  46. Rajgor, 2021, The coordination of local translation, membranous organelle trafficking, and synaptic plasticity in neurons, Front. Cell Dev. Biol., 9, 10.3389/fcell.2021.711446 · DOI
  47. Alberini, 2012, Memory enhancement: consolidation, reconsolidation and insulin-like growth factor 2, Trends Neurosci., 35, 274, 10.1016/j.tins.2011.12.007 · DOI
  48. Lim, 2018, Premature hippocampus-dependent memory decline in middle-aged females of a genetic rat model of depression, Behav. Brain Res., 353, 242, 10.1016/j.bbr.2018.02.030 · DOI
  49. Pardo, 2017, Intranasal siRNA administration reveals IGF2 deficiency contributes to impaired cognition in Fragile X syndrome mice, JCI Insight, 2, 10.1172/jci.insight.91782 · DOI
  50. García-Huerta, 2020, Insulin-like growth factor 2 (IGF2) protects against Huntington’s disease through the extracellular disposal of protein aggregates, Acta Neuropathol., 140, 737, 10.1007/s00401-020-02183-1 · DOI
  51. Troncoso-Escudero, 2021, Insulin-like growth factor 2: beyond its role in hippocampal-dependent memory, J. Cell. Immunol., 3, 46
  52. Tham, 1993, Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type, J. Neural Transm. Park. Dis. Dement. Sect., 5, 165, 10.1007/BF02257671 · DOI
  53. Amritraj, 2009, Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains, Neurobiol. Aging, 30, 54, 10.1016/j.neurobiolaging.2007.05.004 · DOI
  54. Hertze, 2014, Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study, BMC Neurol., 14, 64, 10.1186/1471-2377-14-64 · DOI
  55. Mellott, 2014, IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer’s disease model mice, PLoS One, 9, 10.1371/journal.pone.0094287 · DOI
  56. Pascual-Lucas, 2014, Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice, EMBO Mol. Med., 6, 1246, 10.15252/emmm.201404228 · DOI
  57. Åberg, 2015, Increased cerebrospinal fluid level of insulin-like growth factor-ii in male patients with Alzheimer’s disease, J. Alzheimers Dis., 48, 637, 10.3233/JAD-150351 · DOI
  58. Liou, 2019, Altered brain expression of insulin and insulin-like growth factors in frontotemporal lobar degeneration: another degenerative disease linked to dysregulation of insulin metabolic pathways, ASN Neuro., 11, 10.1177/1759091419839515 · DOI
  59. Xia, 2019, Genome-wide RNA sequencing analysis reveals that IGF-2 attenuates memory decline, oxidative stress and amyloid plaques in an Alzheimer’s disease mouse model (AD) by activating the PI3K/AKT/CREB signaling pathway, Int. Psychogeriatr., 31, 947, 10.1017/S1041610219000383 · DOI
  60. Claros, 2021, Insulin-like growth factor II prevents MPP+ and glucocorticoid mitochondrial-oxidative and neuronal damage in dopaminergic neurons, Antioxidants (Basel), 11, 41, 10.3390/antiox11010041 · DOI
  61. Sepúlveda, 2022, Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson’s disease, Sci. Rep., 12, 2038, 10.1038/s41598-022-05941-1 · DOI
  62. Chao, 2020, Changes of serum insulin-like growth factor-2 response to negative symptom improvements in schizophrenia patients treated with atypical antipsychotics, Curr. Med. Sci., 40, 563, 10.1007/s11596-020-2214-0 · DOI
  63. Yang, 2020, Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia, PLoS One, 15
  64. Vafaee, 2020, Insulin-like growth factor 2 (IGF-2) regulates neuronal density and IGF-2 distribution following hippocampal intracerebral hemorrhage, J. Stroke Cerebrovasc. Dis., 29, 10.1016/j.jstrokecerebrovasdis.2020.105128 · DOI
  65. Åberg, 2021, Insulin-like growth factor-II and ischemic stroke—a prospective observational study, Life (Basel), 11, 499
  66. Martín-Montañez, 2017, IGF-II promotes neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids, Redox Biol., 13, 69, 10.1016/j.redox.2017.05.012 · DOI
  67. Guan, 2021, The mechanism of enriched environment repairing the learning and memory impairment in offspring of prenatal stress by regulating the expression of activity-regulated cytoskeletal-associated and insulin-like growth factor-2 in hippocampus, Environ. Health Prev. Med., 26, 8, 10.1186/s12199-020-00929-7 · DOI
  68. Mackay, 2003, Neuroprotective effects of insulin-like growth factor-binding protein ligand inhibitors in vitro and in vivo, J. Cereb. Blood Flow Metab., 23, 1160, 10.1097/01.WCB.0000087091.01171.AE · DOI
  69. Guan, 1996, The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins, Endocrinology, 137, 893, 10.1210/endo.137.3.8603600 · DOI
  70. Li, 2017, The behavioral deficits and cognitive impairment are correlated with decreased IGF-II and ERK in depressed mice induced by chronic unpredictable stress, Int. J. Neurosci., 127, 1096, 10.1080/00207454.2017.1337014 · DOI
  71. Poggini, 2019, Combined fluoxetine and metformin treatment potentiates antidepressant efficacy increasing IGF2 expression in the dorsal hippocampus, Neural Plast., 2019, 10.1155/2019/4651031 · DOI
  72. Allodi, 2016, Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS, Sci. Rep., 6, 25960, 10.1038/srep25960 · DOI
  73. Osborn, 2018, Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression, Neurobiol. Dis., 110, 218, 10.1016/j.nbd.2017.11.002 · DOI
  74. Near, 1992, Insulin-like growth factor II stimulates motor nerve regeneration, Proc. Natl. Acad. Sci. U. S. A., 89, 11716, 10.1073/pnas.89.24.11716 · DOI
  75. Glazner, 1993, Insulin-like growth factor II increases the rate of sciatic nerve regeneration in rats, Neuroscience, 54, 791, 10.1016/0306-4522(93)90248-E · DOI
  76. Hedlund, 2010, Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection, Brain, 133, 2313, 10.1093/brain/awq167 · DOI
  77. Martin-Montañez, 2014, Involvement of IGF-II receptors in the antioxidant and neuroprotective effects of IGF-II on adult cortical neuronal cultures, Biochim. Biophys. Acta, 1842, 1041, 10.1016/j.bbadis.2014.03.010 · DOI
  78. Berg, 2021, Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman syndrome, Mol. Autism, 12, 59, 10.1186/s13229-021-00467-1 · DOI
  79. Redell, 2021, Insulin-like growth factor-2 (IGF-2) does not improve memory in the chronic stage of traumatic brain injury in rodents, Neurotrauma Rep., 2, 453, 10.1089/neur.2021.0031 · DOI
  80. Molnár, 2020, Pericyte-secreted IGF2 promotes breast cancer brain metastasis formation, Mol. Oncol., 14, 2040, 10.1002/1878-0261.12752 · DOI
  81. Lauterio, 1987, Marson L, Daughaday WH, Baile CA. Evidence for the role of insulin-like growth factor II (IGF-II) in the control of food intake, Physiol. Behav., 40, 755, 10.1016/0031-9384(87)90279-4 · DOI
  82. Honda, 2021, Central administration of insulin-like growth factor-2 suppresses food intake in chicks, Neurosci. Lett., 751, 10.1016/j.neulet.2021.135797 · DOI
  83. Akanji, 2007, Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects, Clin. Chem. Lab. Med., 45, 1229, 10.1515/CCLM.2007.265 · DOI
  84. Riikonen, 2006, Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism, Dev. Med. Child Neurol., 48, 751, 10.1017/S0012162206001605 · DOI
  85. Steen, 2005, Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease--is this type 3 diabetes? J, Alzheimer Dis., 7, 63, 10.3233/JAD-2005-7107 · DOI · Paper page
  86. Agbemenyah, 2014, Insulin growth factor binding protein 7 is a novel target to treat dementia, Neurobiol. Dis., 62, 135, 10.1016/j.nbd.2013.09.011 · DOI
  87. Heywood, 2015, Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay, Mol. Neurodegener., 10, 64, 10.1186/s13024-015-0059-y · DOI
  88. Jiang, 1998, Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation, Neuron., 21, 799, 10.1016/S0896-6273(00)80596-6 · DOI · Paper page
  89. Born, 2017, Strain-dependence of the Angelman syndrome phenotypes in Ube3a maternal deficiency mice, Sci. Rep., 7, 8451, 10.1038/s41598-017-08825-x · DOI
  90. Stoppel, 2017, Hypersociability in the Angelman syndrome mouse model, Exp. Neurol., 293, 137, 10.1016/j.expneurol.2017.04.002 · DOI
  91. Kumar, 2019, Simvastatin restores HDAC1/2 activity and improves behavioral deficits in Angelman syndrome model mouse, Front. Mol. Neurosci., 12, 289, 10.3389/fnmol.2019.00289 · DOI
  92. Pandey, 2021, Autophagy coupled to translation is required for long-term memory, Autophagy, 17, 1614, 10.1080/15548627.2020.1775393 · DOI
  93. Cioni, 2019, Late endosomes act as mRNA translation platforms and sustain mitochondria in axons, Cell, 176, 56, 10.1016/j.cell.2018.11.030 · DOI
  94. Saitoh, 2022, Endosomal recycling defects and neurodevelopmental disorders, Cells, 11, 148, 10.3390/cells11010148 · DOI · Paper page
  95. Nixon, 2013, The role of autophagy in neurodegenerative disease, Nat. Med., 19, 983, 10.1038/nm.3232 · DOI · Paper page
  96. Wong, 2010, Autophagy gone awry in neurodegenerative diseases, Nat. Neurosci., 13, 805, 10.1038/nn.2575 · DOI · Paper page
  97. Müntjes, 2021, Linking transport and translation of mRNAs with endosomes and mitochondria, EMBO Rep. 5, 22
  98. Rangaraju, 2019, Spatially stable mitochondrial compartments fuel local translation during plasticity, Cell., 176, 73, 10.1016/j.cell.2018.12.013 · DOI
  99. Zhu, 2021, IGF2 deficiency causes mitochondrial defects in skeletal muscle, Clin. Sci., 135, 979, 10.1042/CS20210128 · DOI
  100. Gui, 2021, Knockdown of the insulin-like growth factor 2 gene disrupts mitochondrial functions in the liver, J. Mol. Cell Biol., 13, 543
  101. Martin-Montanez, 2021, Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson’s disease, Redox Biol., 46, 10.1016/j.redox.2021.102095 · DOI
  102. Garcia-Fernandez, 2011, Liver mitochondrial dysfunction is reverted by insulin-like growth factor II (IGF-II) in aging rats, J. Transl. Med., 9, 123, 10.1186/1479-5876-9-123 · DOI
  103. Castilla-Cortazar, 2011, Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats, J. Transl. Med., 9, 103, 10.1186/1479-5876-9-103 · DOI

Cited by

Sorted by citations

See all 89

Metadata

Authors
Alberini, C. M.
ORCID
Alberini, Cristina M.
Venue
Trends in Neurosciences
Publisher
Elsevier BV
Published
2023-06
Volume
46
Issue
6
Pages
488-502
ISSN
0166-2236
DOI
10.1016/j.tins.2023.03.007
PMC
PMC10192130
Cited by
89
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review